District of New Jersey Federal Judge Tosses 95 Plavix Cases
District of New Jersey Federal Judge Tosses 95 Plavix Cases

Introduction
U.S. District Judge Freda L. Wolfson dismissed 95 Plavix lawsuits against Bristol-Myers Squibb and Sanofi-Aventis as the patients involved in the MDL failed to respond to the court orders. It remains unclear whether the patients will represent themselves or retain new counsel after the attorneys withdraw the case.
Plavix is an oral antiplatelet prescribed to reduce the risk of a future stroke or heart attack. Lawsuits against the drug maker claim adverse effects like gastrointestinal bleeding, and severe bleeding even with ordinary wounds. Similar cases are consolidated as part of a multidistrict litigation MDL No. 2418 (In Re: Plavix Marketing, Sales Practices, and Product Liability Litigation (No. II)) in the District of New Jersey.
Latest News
Cencora Directors Settle Opioid Oversight Case for $111M
Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids…
Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients
A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…
FDA Adds New Warnings on Long-Term Opioid Risks
Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.
…